Cystic fibrosis is a genetic disorder more common in Caucasians and caused by a mutation in a gene referred to as the CFTR gene (Cystic Fibrosis Transmembrane conductance Regulator gene). The condition is inherited in an autosomal recessive pattern, which means that both parents should have the defective gene for the condition to be passed on to the children. The cystic fibrosis drug ivacaftor has been approved by the US Food and Drug Administration (FDA) to treat patients with mutations that were not approved earlier, thus making the medication accessible to more patients with the disease.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer